Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Osimertinib Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111394747A reveals a novel electrochemical route for 2-acyloxy aniline derivatives, offering significant cost reduction and greener API manufacturing processes.
Patent CN116283922A reveals a Bronsted acid-catalyzed method for EGFR inhibitor intermediates, offering higher yields and metal-free processing for reliable supply chains.